Literature DB >> 28434417

HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA.

Vladimir Guzvic1, Tarik Catic2, Marina Kostic3.   

Abstract

OBJECTIVES: The aim of this study was to describe the healthcare system and health financing in Bosnia and Herzegovina and recent trends in health technology assessment (HTA) placement in the system.
METHODS: A short review of PubMed published literature has been conducted using key words related to reimbursement, HTA, and health policy. We also revised legislation in Bosnia and Herzegovina published in Official Gazettes related to healthcare financing and organization.
RESULTS: A deecentralized system in Bosnia and Herzegovina led to high differences in health policy. HTA has been recognized in legislation in Bosnia and Herzegovina, but it still has not been introduced in practice in full capacity. A small number of publications are found in PubMed treating these issues, but generally the problem of introduction of HTA in Bosnia and Herzegovina is lack of experts, as well as the political environment and education in this field.
CONCLUSIONS: HTA in the Federation of Bosnia and Herzegovina and the Republic of Srpska has a short history because of a huge political impact in the decision-making process, decentralized system, and multiple decision makers in these regions. Challenges remain in assessments, in development of more transparent approaches in different areas of the health system in these regions, and in consistent application of appropriate standards especially in education of professionals who will provide establishment of HTA in the health system of The Federation of Bosnia and Herzegovina and the Republic of Srpska.

Keywords:  Health financing; Health policy; Health technology assessment

Mesh:

Year:  2017        PMID: 28434417     DOI: 10.1017/S0266462317000058

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  Pharmacoeconomic Analysis of Antiepileptic Reimbursement for Neuropathic Pain in Bosnia and Herzegovina - Budget Impact Analysis of Pregabalin.

Authors:  Tarik Catic; Rasim Jusufovic; Vedad Tabakovic
Journal:  Mater Sociomed       Date:  2018-06

2.  Diabetology Care During COVID-19 Lockdown in Bosnia and Herzegovina - Diabetologists and Patients Perspective.

Authors:  Tarik Catic; Rasim Jusufovic; Vedad Tabakovic; Braco Hajdarevic
Journal:  Mater Sociomed       Date:  2020-09

3.  An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries.

Authors:  Maria Kamusheva; Mariya Vassileva; Alexandra Savova; Manoela Manova; Guenka Petrova
Journal:  Front Public Health       Date:  2018-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.